X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs DR. REDDYS LAB - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH DR. REDDYS LAB STERLING BIOTECH/
DR. REDDYS LAB
 
P/E (TTM) x -1.7 28.6 - View Chart
P/BV x 0.1 2.9 2.3% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 STERLING BIOTECH   DR. REDDYS LAB
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
DR. REDDYS LAB
Mar-16
STERLING BIOTECH/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs114,383 0.2%   
Low Rs32,750 0.1%   
Sales per share (Unadj.) Rs26.8920.1 2.9%  
Earnings per share (Unadj.) Rs-15.0126.1 -11.9%  
Cash flow per share (Unadj.) Rs-5.5183.0 -3.0%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs54.9685.8 8.0%  
Shares outstanding (eoy) m267.87170.61 157.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.33.9 6.7%   
Avg P/E ratio x-0.528.3 -1.6%  
P/CF ratio (eoy) x-1.319.5 -6.5%  
Price / Book Value ratio x0.15.2 2.4%  
Dividend payout %015.9 0.0%   
Avg Mkt Cap Rs m1,862608,481 0.3%   
No. of employees `0001.421.7 6.2%   
Total wages/salary Rs m54731,874 1.7%   
Avg. sales/employee Rs Th5,303.37,244.4 73.2%   
Avg. wages/employee Rs Th403.81,470.9 27.5%   
Avg. net profit/employee Rs Th-2,959.0992.8 -298.0%   
INCOME DATA
Net Sales Rs m7,181156,978 4.6%  
Other income Rs m432,693 1.6%   
Total revenues Rs m7,223159,671 4.5%   
Gross profit Rs m94734,587 2.7%  
Depreciation Rs m2,5439,705 26.2%   
Interest Rs m4,377824 531.2%   
Profit before tax Rs m-5,93126,751 -22.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9245,237 -36.7%   
Profit after tax Rs m-4,00721,514 -18.6%  
Gross profit margin %13.222.0 59.8%  
Effective tax rate %32.419.6 165.7%   
Net profit margin %-55.813.7 -407.1%  
BALANCE SHEET DATA
Current assets Rs m14,335118,201 12.1%   
Current liabilities Rs m49,80968,368 72.9%   
Net working cap to sales %-494.031.7 -1,556.2%  
Current ratio x0.31.7 16.6%  
Inventory Days Days40360 672.4%  
Debtors Days Days17197 176.1%  
Net fixed assets Rs m55,43272,265 76.7%   
Share capital Rs m268853 31.4%   
"Free" reserves Rs m13,935111,548 12.5%   
Net worth Rs m14,701117,009 12.6%   
Long term debt Rs m9,47810,690 88.7%   
Total assets Rs m73,988200,104 37.0%  
Interest coverage x-0.433.5 -1.1%   
Debt to equity ratio x0.60.1 705.7%  
Sales to assets ratio x0.10.8 12.4%   
Return on assets %0.511.2 4.5%  
Return on equity %-27.318.4 -148.2%  
Return on capital %-6.421.6 -29.8%  
Exports to sales %25.946.3 56.0%   
Imports to sales %0.29.0 1.9%   
Exports (fob) Rs m1,86072,618 2.6%   
Imports (cif) Rs m1214,050 0.1%   
Fx inflow Rs m1,86075,405 2.5%   
Fx outflow Rs m2527,115 0.1%   
Net fx Rs m1,83548,290 3.8%   
CASH FLOW
From Operations Rs m1,71940,476 4.2%  
From Investments Rs m-3,148-19,421 16.2%  
From Financial Activity Rs m1,426-17,009 -8.4%  
Net Cashflow Rs m-34,046 -0.1%  

Share Holding

Indian Promoters % 33.9 25.5 132.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 9.9 35.3 28.0%  
ADR/GDR % 16.9 18.5 91.4%  
Free float % 39.3 15.3 256.9%  
Shareholders   21,482 75,885 28.3%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   UNICHEM LAB  AUROBINDO PHARMA  CIPLA  ELDER PHARMA  ALEMBIC LTD  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Dr Reddy's: Good show but challenges persist (Quarterly Results Update - Detailed)

Nov 16, 2015

Dr Reddy's has announced its 2QFY16 results. The company has reported 11.2% YoY growth in sales and 25.7% YoY growth in net profits. Here is our analysis of the results.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SUVEN LIFE COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS